MedTrace Logo

Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging

NCT01287910 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2013-09-05

No results posted yet for this study

Summary

The primary goal of this study is to better understand how Transmyocardial Laser Revascularization (TMR) affects the functioning of the heart and, in turn, relieves angina in individuals with coronary heart disease using Magnetic Resonance (MR) images and Computed Tomography (CT) images in some patients.

Conditions

Interventions

OTHER

Cardiac MRI

Cardiac MRI within 30 days prior to TMR procedure and 6 months after TMR procedure.

Sponsors & Collaborators

  • Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.

    collaborator INDUSTRY

  • Piedmont Healthcare

    lead OTHER

Principal Investigators

  • Morris Brown, MD · Piedmont Heart Institute

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01287910 on ClinicalTrials.gov